Clinical Trial Update: The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating fenofibrate for microvascular eye complications in Type 1 diabetes shows the study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Diabetic Retinopathy
• Type 1 Diabetes Mellitus

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: University of Sydney | Conditions: Type 1 Diabetes Mellitus, Diabetic Retinopathy | Phase 3 | Status: ACTIVE_NOT_RECRUITING